Fracasso C, Guiso G, Garattini S, Caccia S
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Appetite. 1988 Feb;10(1):45-55. doi: 10.1016/s0195-6663(88)80032-1.
The anorectic drug D-fenfluramine (D-F) was administered as single i.v. doses of 1.25 and 6.25 mg/kg to lean female Sprague-Dawley and lean and obese female Zucker rats. Blood samples were collected serially and analysed by electron capture gas-liquid chromatography for D-F and its main metabolite, D-norfenfluramine (D-NF). At the lowest dose the disappearance of D-F followed an apparent first-order process with mean elimination half-life (T1/2) of approximately 2 h in female Sprague-Dawley and 4 h in lean and obese Zucker rats. Mean absolute steady-state volume of distribution (Vss) was the same in the lean female of both strains but total clearance (Cl) was significantly lower in the Zucker rats. Therefore elimination T1/2 of D-F was longer in female Zucker than Sprague-Dawley animals. Obese rats presented lower relative Cl and Vss but no change in absolute Cl and Vss and elimination T1/2 of the drug. Intra- and inter-strain differences were observed in hepatic microsomal protein and P-450 content. As in the case of D-F the elimination T1/2 of D-NF was also longer in Zucker than Sprague-Dawley rats. No differences were observed between lean and obese rats but in all cases the elimination T1/2 of the metabolite was much longer than that of its parent drug. After larger doses (6.25 mg/kg) the kinetics of the drug were not linear. The apparent Cl declined changing the metabolite-to-parent drug ratios in all types of rats, but more evidently in Zucker than Sprague-Dawley rats and in obese than lean animals. Inter- and intra-strain differences in D-F and D-NF kinetics should be considered in neurochemical studies of the drug and extrapolation of data across animal species requires consideration of dose dependence in the rat.
将食欲抑制剂D - 芬氟拉明(D - F)以1.25和6.25毫克/千克的单次静脉注射剂量给予瘦型雌性斯普拉格 - 道利大鼠以及瘦型和肥胖型雌性 Zucker 大鼠。连续采集血样,并通过电子捕获气液色谱法分析D - F及其主要代谢物D - 去甲芬氟拉明(D - NF)。在最低剂量下,D - F的消除遵循明显的一级过程,雌性斯普拉格 - 道利大鼠的平均消除半衰期(T1/2)约为2小时,瘦型和肥胖型 Zucker 大鼠为4小时。两种品系的瘦型雌性大鼠的平均绝对稳态分布容积(Vss)相同,但 Zucker 大鼠的总清除率(Cl)显著较低。因此,雌性 Zucker 大鼠中D - F的消除T1/2比雌性斯普拉格 - 道利大鼠更长。肥胖大鼠的相对Cl和Vss较低,但药物的绝对Cl、Vss和消除T1/2没有变化。在肝微粒体蛋白和P - 450含量方面观察到品系内和品系间的差异。与D - F的情况一样,Zucker大鼠中D - NF的消除T1/2也比斯普拉格 - 道利大鼠更长。瘦型和肥胖型大鼠之间未观察到差异,但在所有情况下,代谢物的消除T1/2都比其母体药物长得多。给予较大剂量(6.25毫克/千克)后,药物动力学呈非线性。所有类型大鼠的表观Cl均下降,改变了代谢物与母体药物的比例,但在Zucker大鼠中比在斯普拉格 - 道利大鼠中更明显,在肥胖动物中比在瘦型动物中更明显。在该药物的神经化学研究中应考虑D - F和D - NF动力学的品系间和品系内差异,并且跨动物物种的数据外推需要考虑大鼠中的剂量依赖性。